Results 111 to 120 of about 630 (147)
Some of the next articles are maybe not open access.

Posaconazole

Drugs of Today, 2005
Invasive fungal infections are occurring with increasing frequency secondary to medical advances in the areas of transplantation, cancer management and autoimmune diseases. Unfortunately, the currently available antifungal armamentarium does not meet the increasing needs of managing infection in these complex patient populations.
Elizabeth S, Dodds Ashley   +1 more
openaire   +4 more sources

Costo Efectividad de Posaconazol versus Fluconazol/Itraconazol en el Tratamiento Profiláctico de las Infecciones Fúngicas Invasivas en México

open access: yesValue in Health, 2011
Cost effectiveness of posaconazole versus fluconazole/itraconazole therapy in the prophylaxis against invasive fungal Infections among high-risk neutropenic patients in Mexico.ObjectiveTo estimate the cost effectiveness and long-term combined effects of ...
Guillermo Salinas Escudero
exaly   +2 more sources

Safety of posaconazole

Expert Opinion on Drug Safety, 2013
The increasing number of invasive fungal infections (IFI) among immunocompromised hosts is a significant clinical issue. Diagnosis of IFI, choosing among the available antifungal drugs, and the high morbidity/mortality associated with IFI pose clinical challenges for healthcare providers.
Pauline L, Jacinto   +1 more
openaire   +2 more sources

Posaconazole

Reactions Weekly, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy